血浆受体相互作用蛋白激酶1和混合系列蛋白激酶结构域蛋白与急性冠状动脉综合征患者经皮冠状动脉介入术后主要不良心血管事件的关系被引量：6

Relationships of plasma receptor interacting protein kinase 1 and mixed lineage kinase domain-like protein with major adverse cardiovascular event after percutaneous coronary intervention in patients with acute coronary syndrome

原文传递

导出

摘要目的观察急性冠状动脉综合征(acute coronary syndrome, ACS)患者血浆受体相互作用蛋白激酶1(receptor interacting protein kinase 1, RIPK1)及混合系列蛋白激酶结构域蛋白(mixed lineage kinase domain-like protein, MLKL)水平变化,探讨其对经皮冠状动脉介入治疗(percutaneous coronary intervention, PCI)术后发生主要不良心血管事件(major adverse cardiovascular event, MACE)的预测价值。方法行PCI术的ACS患者174例为ACS组,同期体检健康者62例为对照组,采用ELISA法检测PCI术前2组血浆RIPK1和MLKL水平。ACS患者PCI术后随访1年,根据MACE发生情况分为MACE组40例与无MACE组134例,比较2组临床资料及血浆RIPK1、MLKL水平,采用多因素Cox回归分析ACS患者PCI术后发生MACE的影响因素;绘制ROC曲线,评估血浆RIPK1和MLKL水平对ACS患者PCI术后发生MACE的预测效能。结果 ACS组血浆RIPK1[(6.02±1.45)ng/L]、MLKL[(3.95±1.43)ng/L]水平均高于对照组[(1.94±0.15)、(0.53±0.07)ng/L](t=22.137,P<0.001;t=18.799,P<0.001)。MACE组有吸烟史比率(60.00%)、发病至就诊时间[(14.70±1.56)h]、血糖[(5.40±1.18)mmol/L]、低密度脂蛋白胆固醇[(2.87±0.97)mmol/L]、血浆RIPK1[(7.20±1.45)ng/L]、MLKL[(5.23±1.36)ng/L]水平均高于无MACE组[43.28%、(12.70±1.48)h、(2.87±0.97)mmol/L、(2.42±0.97)mmol/L、(5.67±1.25)ng/L、(3.57±1.22)ng/L](P<0.05),左室射血分数[(55.34±4.32)%]低于无MACE组[(59.99±4.35)%](P<0.05)。发病至就诊时间(HR=1.237,95%CI:0.993~1.540,P=0.003)、左室射血分数(HR=0.915,95%CI:0.843~0.994,P=0.035)和PCI术前血浆RIPK1(HR=1.332,95%CI:1.008~1.761,P=0.044)、MLKL(HR=1.670,95%CI:1.354~2.059,P<0.001)水平是ACS患者PCI术后发生MACE的影响因素。当血浆RIPK、MLKL水平的最佳截断值为6.27、4.06 ng/L时,二者联合检测预测ACS患者PCI术后发生MACE的AUC[0.929(95%CI:0.880~0.962,P<0.001)]大于RIPK1[0.782(95%CI:0.713~0.841,P<0.001)]、MLKL[0.811(95%CI:0.745~0.867,P<0.001)]单独检测(Z=3.100,P=0.002;Z=2.776,P=0.006),灵敏度为80.00%,特异度为89.55%,准确率为87.35%。结论 ACS患者血浆RIPK1和MLKL水平升高,PCI术前血浆RIPK1和MLKL水平升高的ACS患者PCI术后发生MACE的风险增高,二者联合检测对ACS患者PCI术后发生MACE有较高预测价值。 Objective To observe the expressions of plasma receptor interacting kinase 1 (RIPK1)and mixed lineage kinase domain-like protein(MLKL)in patients with acute coronary syndrome(ACS),and to investigate their predictive values to the occurrence of major adverse cardiovascular event(MACE)after percutaneous coronary intervention(PCI).Methods The levels of plasma RIPK1and MLKL were detected by ELISA before PCI in 174patients with ACS receiving PCI(ACS group)and 62healthy volunteers(control group).ACS patients were followed up for one year after PCI and were divided into MACE group (n=40)and no-MACE group (n=134)according to the occurrence of MACE.The clinical data and plasma RIPK1 and MLKL levels were compared between MACE group and no-MACE group.Multivariate Cox regression analysis was done to assess the influencing factors of MACE after PCI in ACS patients.ROC curve was drawn to assess the predictive efficiencies of plasma RIPK1and MLKL levels on MACE after PCI in ACS patients.Results The levels of plasma RIPK1and MLKL were higher in ACS group[(6.02±1.45),(3.95±1.43)ng/L]than those in control group[(1.94±0.15),(0.53±0.07)ng/L](t=22.137,P<0.001;t=18.799,P<0.001).MACE group had higher percentage of patients with smoking history,longer onset-to-visit time,higher levels of plasma glucose,low-density lipoprotein cholesterol,plasma RIPK1and MLKL,and lower left ventricular ejection fraction[60.00%,(14.70±1.56)h,(5.40±1.118)mmol/L,(2.87±0.97)mmol/L,(7.20±1.45)ng/L,(5.23±1.36)ng/L,(55.34±4.32)%]than no-MACE group[43.28%,(12.70±1.48)h,(2.87±0.97)mmol/L,(2.42±0.97)mmol/L,(5.67±1.25)ng/L,(3.57±1.22)ng/L,(59.99±4.35)%](P<0.05).The onset-to-visit time(HR=1.237,95%CI:0.993-1.540,P=0.003),left ventricular ejection fraction (HR=0.915,95%CI:0.843-0.994,P=0.035),preoperative level of plasma RIPK1 (HR=1.332,95%CI:1.008-1.761,P=0.044)and MLKL (HR=1.670,95%CI:1.354-2.059,P<0.001)were the influencing factors of MACE after PCI in ACS patients.When the optimal cut-off values of plasma RIPK and MLKL were 6.27ng/L and 4.06ng/L,the AUCof combined detection of them two[0.929(95%CI:0.880-0.962,P<0.001)]was greater than that of single detection of RIPK1[0.782 (95%CI:0.713-0.841,P<0.001)]and MLKL[0.811 (95%CI:0.745-0.867,P<0.001)]for predicting MACE after PCI in ACS patients (Z=3.100,P=0.002;Z=2.776,P=0.006),with a sensitivity of80.00%,a specificity of 89.55%and an accuracy of 87.35%.Conclusions Plasma RIPK1and MLKL levels increase in ACS patients,and those with increased levels of RIPK1and MLKL before PCI have an increased risk of MACE after PCI.The combined detection of plasma RIPK1and MLKL have a high predictive value to MACE after PCI in ACS patients.

作者蔡治钢王双玲张峰 CAI Zhi-gang;WANG Shuang-ling;ZHANG Feng(Department of Emergency,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 101121,China)

机构地区北京中医药大学东直门医院急诊科

出处《中华实用诊断与治疗杂志》 2022年第2期161-164,共4页 Journal of Chinese Practical Diagnosis and Therapy

基金首都卫生发展科研专项项目(首发2017-3-0211)。

关键词急性冠状动脉综合征经皮冠状动脉介入治疗受体相互作用蛋白激酶1 混合系列蛋白激酶结构域蛋白 acute coronary syndrome percutaneous coronary intervention receptor interacting protein kinase 1 mixed lineage kinase domain-like protein

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献5

1中国经皮冠状动脉介入治疗指南（2016）[J].中华心血管病杂志,2016,44(5):382-400. 被引量：1560
2邢帅帅,贾梦奇,赵根尚.血清可溶性肿瘤发生抑制蛋白2和SYNTAX积分与冠状动脉旁路移植术患者近期预后的关系[J].中华实用诊断与治疗杂志,2021,35(4):372-375. 被引量：6
3郭双,邢栋,吕勃.细胞凋亡及细胞程序性坏死和细胞焦亡的研究进展[J].中华实用诊断与治疗杂志,2021,35(3):321-324. 被引量：35
4崔路乾,董淑娟,李静超,余海佳,韩永梅,宋慧慧,楚英杰.预测ST段抬高型心肌梗死患者急诊经皮冠状动脉介入术后发生主要不良心血管事件风险的列线图模型构建[J].中华实用诊断与治疗杂志,2021,35(4):367-371. 被引量：24
5急性冠脉综合征急诊快速诊疗指南[J].中华急诊医学杂志,2016,25(4):397-404. 被引量：541

二级参考文献78

1杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量：73
2Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2016, 37 (3) : 267-315. DOI: 10. 1016/j. rec. 2015. 10. 009.
3Nabi F, Chang SM, Xu J, et al. Assessing risk in acute chest pain : The value of stress myocardial perfusion imaging in patients admitted through the emergency department [ J]. J Nucl Cardiol, 2012, 19 (2): 233-243. DOI: 10. 1007/s12350-011-9484-7.
4Shah BN, Balaji G, Alhajiri A, et al. Incremental diagnostic and prognostic value of contemporary stress echocardiography in a chest pain unit: mortality and morbidity outcomes from a real-world setting [J]. Cardiovasc Imaging, 2013, 6 (2): 202-209. DOI: 10. ll61/CIRCIMAGING. 112. 980797.
5Huhen E, Pickett C, Bittencourt MS, et al. Outcomes after coronary computed tomography angiography in theemergency department: a systematic review and meta-analysis of randomized, controlled trials [J]. J Am Coil Cardiol, 2013, 61 (8): 880- 892. DOI: 10. 1016/j. jacc. 2009. 02. 008.
6Mueller C, Giannitsis E, Christ M, et al. Multicenter evaluation of a 0-hour/l-hour algorithm in the diagnosis ofmyocardial infarction with high-sensitivity cardiac troponin T [ J ]. Ann Emerg Med, 2016, pii: S0196-0644 (15) 01501-2. DOI: 10. 1016/j. annemergrned. 2015. 11. 013.
7Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T [J]. Arch Intern Med, 2012, 172 (16) : 1211-1218. DOI: 10. 1001/archintemmed. 2012. 3698.
8Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [J]. Eur Heart J, 2012, 33 (20) : 2569-2619. DOI: 10. 1093/eurheartj/ehs215.
9Fox KA, Fitzgerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk Derivation, external validation and outcomes using the updated GRACE risk score [J]. BMJ Open, 2014, 4 (2): e4425. DOI: 10. 1136/bmjopen-2013-O04425.
10Abu-Assi E, Raposeiras-Roubin S, Iear P, et al. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome [J]. Eur Heart J Acute Cardiovasc Care, 2012, 1 (3): 222-231. DOI: 10. 1177/2048872612453924.